Skip to main content
Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.200
+0.005 (2.62%)
At close: Apr 28, 2026

Northwest Biotherapeutics Revenue

In the year 2025, Northwest Biotherapeutics had annual revenue of $1.38M, down -0.29%. Northwest Biotherapeutics had revenue of $672.00K in the quarter ending December 31, 2025, with 190.91% growth.

Revenue
1.38M
Revenue Growth
-0.29%
P/S Ratio
236.46
Revenue / Employee
13.12K
Employees
25
Market Cap
325.84M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.38M-4.00K-0.29%
Dec 31, 20241.38M-550.00K-28.47%
Dec 31, 20231.93M249.00K14.80%
Dec 31, 20221.68M678.00K67.46%
Dec 31, 20211.01M-286.00K-22.15%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Northwest Biotherapeutics News

More News